# Wallaby Medical acquires phenox GmbH for EUR 500 million

Wallaby Medical has acquired German neurovascular device company phenox GmbH, including its subsidiary femtos GmbH, for a total consideration of approximately EUR 500 million including milestone payments. The transaction has received all regulatory approvals and has been completed.

- Type: Acquisition
- Announced: 2022-04-21
- Where: Bochum, Germany, Germany
- Value: $540.0M (500.0M EUR)
- Status: completed
- Products: neurovascular interventional devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [phenox](https://endata.com/companies/44105.md) (target)
- [Wallaby Medical](https://endata.com/companies/44106.md) (acquirer)
- [femtos GmbH](https://endata.com/companies/62414.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/wallaby-acquires-german-neurovascular-leader-phenox-to-accelerate-global-expansion-301529703.html), 2022-04-21: "Wallaby Medical today announced that it has acquired phenox GmbH, including phenox's femtos GmbH, for a total consideration of approximately EUR 500 million including milestone payments."
- [medcitynews.com](https://medcitynews.com/2022/04/wallaby-medical-acquires-phenox-gmbh-to-broaden-its-stroke-treatment-and-prevention-product-pipeline/), 2022-04-21: "The market for neurovascular medical devices is forecasted to grow considerably, driven by an aging population and the increasing focus on diagnosing and treating stroke."
- [wsgr.com](https://www.wsgr.com/en/insights/wilson-sonsini-advises-wallaby-on-eur-500-million-acquisition-of-phenox.html), 2022-04-27: "Wallaby Medical, a global innovative medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke, announced that it has acquired phenox GmbH"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.